Cystic Fibrosis News Today
Skip to content
  • Home
  • Columns
    • The Patient’s Perspective
    • Victorious
    • Not Your Average Rose
    • Life In the Grey
    • CF Regenerative Medicine
    • An Undeniable Hope
  • News Categories
    • CF Foundation
    • Pseudomonas Aeruginosa
    • Kalydeco
    • FDA
    • Fundraising
    • Orkambi
    • Social Clips
  • CF Overview
    • Cystic Fibrosis Symptoms
    • Cystic Fibrosis Diagnosis
    • Cystic Fibrosis Prognosis & Therapies
    • Cystic Fibrosis Life Expectancy
    • Cystic Fibrosis Causes
      • Cystic Fibrosis Genetics
    • Living with Cystic Fibrosis
      • Cystic Fibrosis-related Diabetes (CFRD)
      • Cystic Fibrosis in Children
      • Cystic Fibrosis and Exercise
      • Cystic Fibrosis and Emotional Wellness
      • Cystic Fibrosis and Nutrition
      • Caring for a Family Member with Cystic Fibrosis
      • Cystic Fibrosis and Sexuality
    • Cystic Fibrosis Overview
      • Cystic Fibrosis Research
    • Cystic Fibrosis Foundation
    • Pseudomonas aeruginosa
    • Osteoporosis and Osteopenia in Cystic Fibrosis
  • Treatments
    • Kalydeco
    • Orkambi
    • Antibiotics
      • Amikin (amikacin)
      • Aminoglycosides
      • Azithromycin
      • Aztreonam
      • Gentamicin
      • Cephalosporins
      • Linezolid (Zyvox)
      • Macrolides
      • Penicillin
      • Quinolones
      • Sulfonamides
      • Tetracyclines
      • Tobramycin
    • Mucolytics
      • Bronchodilators for CF – Albuterol (Ventolin, Proventil)
      • Bronchodilators for CF – Levalbuterol Hydrochloride (Xopenex)
      • Hypertonic Saline
      • Dornase Alfa
      • Pulmozyme (Dornase Alfa)
    • Enzymes
      • Pancreatin/Pancrelipase
      • PERT
      • Probiotics and Prebiotics for Cystic Fibrosis
    • Experimental Therapies
      • CF Therapy Tracker
        • Acebilustat (Formerly CTX-4430)
        • Aerovanc (Vancomycin Inhalation Powder)
        • Ataluren
        • AZD5634
        • Cavosonstat (N91115)
        • CRISPR/Cas9
        • CTP-656
        • FDL169
        • Fosfomycin/Tobramycin
        • Gallium
        • Glutathione
        • Inhalable Ibuprofen
        • Inhaled Levofloxacin (Quinsair)
        • Inhaled Liposomal Amikacin
        • GS-5745
        • LAU-7b
        • Liprotamase
        • OligoG
        • Nitric Oxide (Inhaled)
        • POL6014
        • PTI-428
        • PTI-808
        • QBW251
        • QR-010
        • Resunab (formerly JBT-101)
        • Riociguat
        • SPX-101
        • Tezacaftor (VX-661)
        • Theradux (formerly OrPro and ORP-100)
        • VX-152
        • VX-371 (Formerly P-1037)
        • VX-440
        • VX-659
        • TEZ/IVA – Tezacaftor/Ivacaftor Combo Therapy
      • Lumacaftor (VX-809)
    • Cystic Fibrosis and Vitamins
      • AquADEKs for Nutritional-GI in CF
  • Resources
    • The Pfizer Therapeutic Program for Cystic Fibrosis
    • The Sanofi Genzyme Therapeutic Program for Cystic Fibrosis
    • The Southern Research Therapeutic Program for Cystic Fibrosis

Members

April 8, 2014July 4, 2016
adminby admin

Home » Members

[symposium-members]

Subscribe to our mailing list

* indicates required


Recent CF Posts

  • European Cystic Fibrosis Conference

    My Thoughts on the European Cystic Fibrosis Conference (ECFS 2018)

    June 19, 2018

  • WVU CFF accreditation

    WVU Medicine Granted CFF Accreditation for its Adult Cystic Fibrosis Program

    June 19, 2018

  • progression, struggle, living with lung disease

    Progression, Personality, and Perseverance

    June 18, 2018

  • ECFS conference remote monitoring

    #ECFS2018 — Can Remote Monitoring Really Revolutionize Cystic Fibrosis Care?

    June 18, 2018

  • Vertex Foundation matching gift program

    Vertex Employees Donate $1M to CF and Other Communities via Matching Gift Program

    June 18, 2018


You May Also Like…

Cystic Fibrosis Foundation Awards $11M to Develop Therapies for Patients with Nonsense Mutations

May 8, 2018

Cystic Fibrosis Foundation

Do I Have Trouble Planning for the Future?

May 7, 2018

sunset, planning for the future

Cystic Fibrosis Didn’t Shatter Me — It Forged Bravery

May 1, 2018

bravery
Visit Cystic Fibrosis News Today's profile on Pinterest.

CF News Today


BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: [email protected]
Phone: 1-800-936-1363

BioNews Feed

Recent Posts

  • European Cystic Fibrosis Conference

    My Thoughts on the European Cystic Fibrosis Conference (ECFS 2018)

    June 19, 2018

  • WVU CFF accreditation

    WVU Medicine Granted CFF Accreditation for its Adult Cystic Fibrosis Program

    June 19, 2018

  • progression, struggle, living with lung disease

    Progression, Personality, and Perseverance

    June 18, 2018

  • ECFS conference remote monitoring

    #ECFS2018 — Can Remote Monitoring Really Revolutionize Cystic Fibrosis Care?

    June 18, 2018

  • About CF News Today
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Advertising
  • Cystic Fibrosis Resources

Disclaimer:

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2018 All rights reserved.

Pin It on Pinterest

Share This
  • Facebook
  • Twitter
  • Google+
  • Pinterest
  • LinkedIn
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more